Painkiller marketer heads off competition in OTC med awards
October 26, 2012
Painkiller marketer heads off competition in OTC medicines awards
Suzanne Yee, Reckitt Benckiser senior brand manager, was named Supreme Award winner in the New Zealand Self Medication Industry Association (SMI) awards announced last night at the SMI conference dinner at SkyCity in Auckland.
These prestigious industry awards are in their fourth year and are an opportunity for top achievers to be recognised by their peers.
Ms Yee won the top award for her overall marketing excellence in over-the-counter medicines. She also won an award for Best Launch of a New Product for the launch of the strong pain reliever Nuromol. She was a joint winner, along with Shannon Kelly of Pharmacybrands, in the Best Self Care Campaign award for the “Be Sure” campaign which invited consumers to seek advice on suitable pain medication from pharmacists, and she was named runner-up in the same category for the Nuromol launch.
“We had a high calibre of entries this year but Suzanne’s work stood out and the judging panel felt the Supreme Award should be given to an individual rather than a brand this year,” explains SMI executive director, Tim Roper.
The Best Advertising and Promotional Campaign award was won by Paul Bickerton of Reckitt Benckiser for the Nurofen for Children campaign. Bryn Marriott of Johnson & Johnson was runner-up in this category for his “Expert Relief” campaign for Codral/Sudafed in pharmacy and grocery.
About SMI: The New Zealand Self-Medication Industry Association Inc (SMI) is the national trade association representing manufacturers, marketers and distributors of a wide range of products, generally available "over-the-counter" (OTC) and mainly for use in self-medication by New Zealand consumers. SMI’s mission is to promote better health through responsible self-care. This means ensuring that safe and effective self-care products are readily available to all New Zealanders at a reasonable cost. SMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy.